Clinical Evaluation of Pertussis Vaccines: Us Food and Drug Administration Regulatory Considerations
The journal of infectious diseases (Online University of Chicago Press)/The Journal of infectious diseases(2014)
Abstract
The resurgence of pertussis in the United States has stimulated considerable public health interest in developing new vaccination strategies to improve control of pertussis. The purpose of this article is to review the US Food and Drug Administration's regulatory framework for the prelicensure clinical evaluation of preventive vaccines and the clinical approaches that have been used to demonstrate effectiveness of US-licensed vaccines containing an acellular pertussis component.
MoreTranslated text
Key words
pertussis vaccines,regulatory pathways,vaccine effectiveness
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined